These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16439861)

  • 1. Perillyl alcohol induces c-Myc-dependent apoptosis in Bcr/Abl-transformed leukemia cells.
    Clark SS
    Oncology; 2006; 70(1):13-8. PubMed ID: 16439861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest.
    Clark SS; Perman SM; Sahin MB; Jenkins GJ; Elegbede JA
    Leukemia; 2002 Feb; 16(2):213-22. PubMed ID: 11840288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines.
    Sahin MB; Perman SM; Jenkins G; Clark SS
    Leukemia; 1999 Oct; 13(10):1581-91. PubMed ID: 10516760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion.
    Clark SS; Zhong L; Filiault D; Perman S; Ren Z; Gould M; Yang X
    Clin Cancer Res; 2003 Oct; 9(12):4494-504. PubMed ID: 14555523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
    Ask A; Persson L; Rehnholm A; Frostesjö L; Holm I; Heby O
    Cancer Res; 1993 Nov; 53(21):5262-8. PubMed ID: 8221660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
    Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K
    Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells.
    Flamigni F; Faenza I; Marmiroli S; Stanic' I; Giaccari A; Muscari C; Stefanelli C; Rossoni C
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):783-9. PubMed ID: 9210401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
    Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis.
    Packham G; Cleveland JL
    Mol Cell Biol; 1994 Sep; 14(9):5741-7. PubMed ID: 8065308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines.
    Xu Y; Voelter-Mahlknecht S; Mahlknecht U
    Int J Mol Med; 2005 Jan; 15(1):169-72. PubMed ID: 15583844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
    Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
    Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
    Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS
    Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression.
    Nakamura S; Yokota D; Tan L; Nagata Y; Takemura T; Hirano I; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
    Int J Cancer; 2012 Mar; 130(5):1046-59. PubMed ID: 21400515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
    Shantz LM; Levin VA
    Amino Acids; 2007 Aug; 33(2):213-23. PubMed ID: 17443268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.
    Rahmani M; Nguyen TK; Dent P; Grant S
    Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-myc gene regulates the polyamine pathway in DMSO-induced apoptosis.
    Trubiani O; Pieri C; Rapino M; Di Primio R
    Cell Prolif; 1999; 32(2-3):119-29. PubMed ID: 10535358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis.
    Puccetti E; Beissert T; Güller S; Li JE; Hoelzer D; Ottmann OG; Ruthardt M
    Oncogene; 2003 Oct; 22(44):6900-8. PubMed ID: 14534537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
    Wang Z; Sampath J; Fukuda S; Pelus LM
    Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.